The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04678349

Enrollment

Registered

2020-12-21

Start date

2021-05-01

Completion date

2021-11-29

Last updated

2022-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

this is a cross sectional intervention study to investigate the role of partial hydrolyzed guar gum in high stoma output management among cancer patients with ileostomy. This study hypotheses there is improvement in stoma output in PHGG if compare with control. There are two groups of subjects in this study. Conventional group (CG) will include retrospective historical data (those subjects with post-operative ileostomy) from Jan 2016 to June 2019. Intervention group (PHGG) will be subjects with ileostomy which involves prospective intervention by giving partial hydrolyzed guar gum upon start orally. Data on stoma output (volume & consistency), length of hospital stay, readmission within 30-days discharged and dietary intake will be recorded in data collection form.

Interventions

DIETARY_SUPPLEMENTPHGG

Subjects will be given 4 scoops (40g) PHGG, which provide 160kcal, 0.24g protein, 30.4g soluble fibre, 40g carbohydrate and 0g sugar, once allowed orally.

OTHERconventional care

follow low fibre diet and anti-diarrhea drugs

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Cancer patients with ileostomy * At least 18 years of age * Malaysian

Exclusion criteria

* Not cancer patients with ileostomy * Patients who participate in other study at the same time * Vulnerable subjects * Palliative patients * Patient has fistula

Design outcomes

Primary

Measure	Time frame	Description
ileostomy stoma output	up to 1 month	consistency (bristrol stool chart; range 1-7; 1 hard while 7 watery)

Secondary

Measure	Time frame	Description
Length of hospital stay	up to 1 month	days of hospital stays
Readmission within 30-days discharged	up to 1 month	readmit to ward due to complications after discharge
Dietary intake	up to 1 month	energy (kcal/day)
dietary intake	up to 1 month	protein intake (g/day)

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026